Alendronate versus alfacalcidol in the prevention of glucocorticoid-induced bone loss

被引：1
|
作者：
Hahn, Bevra H. [1 ]
Hahn, Theodore J.
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA
[2] W Los Angeles Vet Adm Hlth Care Ctr, Los Angeles, CA USA
来源：
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2007年 / 3卷 / 01期
关键词：
alendronate; alfacalcidol; glucocorticoids; osteoporosis; prevention;
D O I：
10.1038/ncprheum0370
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [31] Metabolic bone diseases: Teriparatide or alendronate for glucocorticoid-induced osteoporosis therapy?
    Nassabeh N.
    Nature Reviews Rheumatology, 2010, 6 (1) : 1 - 1
  • [32] Cost-effectiveness of prevention of glucocorticoid-induced osteoporosis with alendronate or alfacalcidol. The stop-study: A randomized placebo-controlled trial
    De Nijs, R
    Buskens, E
    Jacobs, JW
    Bijlsma, JWJ
    VALUE IN HEALTH, 2005, 8 (06) : A136 - A136
  • [33] Meta-regression analysis of the efficacy of alendronate for prevention of glucocorticoid-induced fractures
    Qiu, Mei
    Ding, Liangliang
    Zhang, Miao
    Lin, Jinhao
    Huang, Hua
    Li, Kaikai
    MEDICINE, 2020, 99 (42)
  • [34] Cell Transitions Contribute to Glucocorticoid-Induced Bone Loss
    Qiao, Xiaojing
    Wu, Xiuju
    Zhao, Yan
    Yang, Yang
    Zhang, Li
    Cai, Xinjiang
    Ma, Jocelyn A. A.
    Ji, Jaden
    Lyons, Karen
    Bostrom, Kristina I. I.
    Yao, Yucheng
    CELLS, 2023, 12 (14)
  • [35] Glucocorticoid-induced bone loss in dermatologic patients - An update
    Summey, BT
    Yosipovitch, G
    ARCHIVES OF DERMATOLOGY, 2006, 142 (01) : 82 - 90
  • [36] Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate
    Eastell, Richard
    Chen, Peiqi
    Saag, Kenneth G.
    Burshell, Alan L.
    Wong, Mayme
    Warner, Margaret R.
    Krege, John H.
    BONE, 2010, 46 (04) : 929 - 934
  • [37] Aqueous extract of pomegranate seed attenuates glucocorticoid-induced bone loss and hypercalciuria in mice: A comparative study with alendronate
    Zhang, Yan
    Shao, Jin
    Wang, Zhi
    Yang, Tieyi
    Liu, Shuyi
    Liu, Yue
    Fan, Xinbing
    Ye, Weiguang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 (02) : 491 - 498
  • [38] Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis
    Saag, K. G.
    Shane, E.
    Boonen, S.
    Donley, D. W.
    Marin, F.
    Warner, M. R.
    Taylor, K. A.
    Dalsky, G. R.
    Marcus, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 117 - 117
  • [39] Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis
    Warner, Margaret R.
    Saag, Kenneth G.
    Shane, Elizabeth
    Boonen, Steven
    Donley, David W.
    Marin, Fernando
    Taylor, Kathleen A.
    Dalsky, Gail P.
    Marcus, Robert
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S222 - S222
  • [40] Cost-effectiveness of prevention of glucocorticoid-induced osteoporosis with alendronate or alfacalcidol. The Stop-Study: A randomized placebo-controlled trial.
    de Nijs, RNJ
    Buskens, E
    de Laet, CED
    Jacobs, JWG
    Lems, WWF
    Laan, RFJ
    Algra, A
    Oostveen, ACM
    Dijkmans, BAC
    Verstappen, SMM
    Bijlsma, JWJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S400 - S401
12345